To hear about similar clinical trials, please enter your email below
Trial Title:
Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）
NCT ID:
NCT06537037
Condition:
Urologic Cancer
Conditions: Official terms:
Urologic Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims
to explore the relationship between the imaging information of urologic cancer patients,
tumor microenvironment and the prognosis of urologic cancer patients.
Criteria for eligibility:
Study pop:
Patients treated for urologic cancer
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to
August 2027;
2. Aged > 18 years old;
3. At least one CT scan or MRI scan before treatment;
4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion criteria：
1. Poor image quality;
2. Incomplete clinical data or loss of follow-up;
3. Presence of another primary malignancy other than urologic cancer;
4. Unclear pathological diagnosis。
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
Address:
City:
Wuhan
Zip:
430000
Country:
China
Status:
Recruiting
Contact:
Last name:
Lian Yang
Phone:
18986273791
Email:
yanglian@hust.edu.cn
Start date:
August 2024
Completion date:
August 2027
Lead sponsor:
Agency:
Wuhan Union Hospital, China
Agency class:
Other
Source:
Wuhan Union Hospital, China
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06537037
